BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6339856)

  • 1. Suppression of voluntary ethanol consumption in rats by gamma-butyrolactone.
    Fadda F; Argiolas A; Melis MR; De Montis G; Gessa GL
    Life Sci; 1983 Mar; 32(13):1471-7. PubMed ID: 6339856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gamma-butyrolactone, amphetamine, and haloperidol in mice differing in sensitivity to alcohol.
    Dudek BC; Fanelli RJ
    Psychopharmacology (Berl); 1980; 68(1):89-97. PubMed ID: 6771802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceleration of the biosynthesis of rat striatal dopamine by incubation and by administration of gamma-butyrolactone.
    Dyck LE; Kazakoff CW
    J Neurosci Res; 1982; 8(1):57-65. PubMed ID: 7175978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of the gamma-butyrolactone-induced increase in DOPA accumulation by chronic ethanol administration.
    Liljequist S; Engel J
    J Neural Transm; 1979; 46(3):195-204. PubMed ID: 528994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic neurons: reversal of effects elicited by gamma-butyrolactone by stimulation of the nigro-neostriatal pathway.
    Murrin LC; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):15-20. PubMed ID: 12482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
    Argiolas A; Fadda F; Melis MR; Marcou M; Porceddu ML; Gessa GL
    Eur J Pharmacol; 1982 Nov; 85(1):23-7. PubMed ID: 6818043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance to the effects of baclofen and gamma-butyrolactone on locomotor activity and dopaminergic neurons in the mouse.
    Gianutsos G; Moore KE
    J Pharmacol Exp Ther; 1978 Dec; 207(3):859-69. PubMed ID: 731436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. gamma-butyrolactone enhances the activity of GABA in the gastric acid secretion of anesthetized rats.
    Watanabe K; Watanabe H; Goto Y; Shimizu M; Maeda-Hagiwara M
    Jpn J Pharmacol; 1983 Dec; 33(6):1163-9. PubMed ID: 6668764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of the relationship between the dopaminergic and electroencephalographic effects of gamma-butyrolactone.
    Snead OC
    Neuropharmacology; 1982 Jun; 21(6):539-43. PubMed ID: 7110537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxicological analyses of voluntary alcohol drinking by the rat.
    Messiha FS
    Neurobehav Toxicol Teratol; 1985; 7(2):155-9. PubMed ID: 3889685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-butyrolactone sleep: A 24-hour rhythm paralleling normal sleep in the rat and CNS amine changes.
    Speciale SG; Friedman AH
    Pharmacol Biochem Behav; 1975; 3(5):761-4. PubMed ID: 1208618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin A, gender and ethanol interactions.
    Messiha FS
    Neurobehav Toxicol Teratol; 1983; 5(2):233-6. PubMed ID: 6346126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gamma-Butyrolactone effects on behavior induced by dopamine agonists.
    Ellinwood EH; Gonzalez AE; Dougherty GG
    Biol Psychiatry; 1983 Sep; 18(9):1023-32. PubMed ID: 6685535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered response to cessation of nerve impulse flow in dopamine neurons after chronic ethanol administration.
    Liljequist S; Engel J
    Adv Exp Med Biol; 1980; 126():157-63. PubMed ID: 6773305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of ethanol intake in ethanol-preferring rats by 1,4-butanediol.
    Colombo G; Mosca E; Gessa GL; Fadda F
    Alcohol; 1990; 7(6):503-5. PubMed ID: 2261087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic gamma-butyrolactone (GBL) treatment: a potential model of dopamine hypoactivity.
    Nowycky MC; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(3):247-54. PubMed ID: 43476
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of ethanol intake following administration of dopamine-beta-hydroxylase inhibitors in rats.
    Amit Z; Levitan DE; Lindros KO
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):114-9. PubMed ID: 999391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroidal actions and voluntary drinking of ethanol by male and female rats.
    Messiha FS
    Prog Biochem Pharmacol; 1981; 18():205-15. PubMed ID: 7031680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papaverine, tetrahydropapaverine and ethanol metabolizing enzymes.
    Messiha FS
    Vet Hum Toxicol; 1990 Apr; 32(2):126-30. PubMed ID: 2327057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chronic ethanol administration on central neurotransmitter mechanisms.
    Liljequist S; Engel J
    Med Biol; 1979 Aug; 57(4):199-210. PubMed ID: 41985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.